Recent
Rewriting Biopharma's Playbook with Mallory Factor, Founder and CEO IntraBio
Ep 148: Rewriting Biopharma's Playbook with Mallory Factor, Founder and CEO IntraBio
Focus on Patients, Not Meetings
Engineering Agency, Innovation, and Ecosystems with Gena Gorlin
Ep 147: Engineering Agency, Innovation, and Ecosystems with Gena Gorlin
Satellite Revolution is Unleashing an Imaging Data Gold Rush
Why Austin Not Silicon Valley Leads Defense Tech Manufacturing
Austin4America Rises From SXSW's Military Sponsor Ban with Luke Fischer, Co-Founder & CEO SkyFi
Ep 146: Austin4America Rises From SXSW's Military Sponsor Ban with Luke Fischer, Founder & CEO SkyFi
Austin Defense Tech Community Counters SXSW Military Sponsor Ban
Growing Space Peppers Leads to Actual Scientific Discoveries
Plants Don't Care About Gravity
Science in the Commercial Space Age: Live from UATX's SOMA Inaugural Summit
Ep 145: Science in the Commercial Space Age - Live from UATX's SOMA Inaugural Summit
Unlocking Space with Reusable Rockets
Listen On
Recent Blog Posts
New Report says Austin is turning into life sciences "superstar" hub
Thrilled to have been featured on 'Tech this Out' with Walt Maciborski, discussing the booming Austin Life Sciences Sector!Our report, 'Austin Life Sciences Sector: A Powerhouse Emerging at a Pivotal Crossroads,' was born from a desire to catalyze a…
Austin's Venture Funding Challenges the Global Stagnation
The global venture funding landscape narrative for the first half of 2023 has been portrayed as one of stagnation. Headlines from notable publications, such as Crunchbase's "AI Was Q2’s Big Hope To Reverse The Global Venture Funding Slowdown. …
Austin Life Sciences Sector: A Powerhouse Emerging at a Pivotal Cross…
Welcome to Austin Next, where we explore Austin's ascension into a global innovation powerhouse. We delve into the region's evolution, examine the building of robust ecosystems, and consider the impact of emerging trends and technologies. With Austi…
About the Host
Jason Scharf
Founder & Host
Jason Scharf has spent nearly two decades pursuing his life’s mission of catalyzing innovation. As an early stage investor, he targets the bio innovation tech stack and the business of health. He has held key leadership roles in strategy and market intelligence at industry pillars such as Illumina, BD, and Amgen. Through the Austin Next podcast and his writings, he explores innovation, Bio & Health, tech, ecosystems, Austin, and their convergence.